Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-08-09
2005-08-09
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007500, C435S007900, C435S007940, C436S501000, C436S814000, C436S818000, C530S387500, C530S388240, C530S389200
Reexamination Certificate
active
06927034
ABSTRACT:
The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
REFERENCES:
patent: 4514505 (1985-04-01), Canfield et al.
patent: 5260421 (1993-11-01), Chappel et al.
patent: 6133048 (2000-10-01), Penfold et al.
patent: 6339143 (2002-01-01), Krichevsky et al.
patent: 6500627 (2002-12-01), O'Connor et al.
patent: WO8804779 (1988-06-01), None
patent: 4300896 (1992-10-01), None
patent: WO9941584 (1999-08-01), None
patent: WO0070094 (2000-11-01), None
Birken et al., Separation of Nicked Human Chorionic Gonadotropin (hCG), intact hCG, and hCGBeta fragments from standard reference preparations and raw urine samples. Endocrinology, 1993, Vol. 133, No. 3, pages 1390-1397.
O'Connor et al., “Development of Highly sensitive immunoassays to measure human chorionic gonadotropin, its beta subunit, and beta core fragments in the urine: Applications to Malignancies”, Cancer Research, 1988, 48, 1361-1366.
Ellish et al., “A prospective study of early pregnancy loss”, Human Reproduction, Vol. 11, No. 2, pp. 406-412, 1996.
Prince et al. “Asian women are at increased risk of gestational thyrotoxicosis.” Journal of Clinical Endocrinology and Metabolism. Vol. 81, No. 3, 1996, pp. 1160-1163.
Cole, L. A. (1998) “hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease,” J. Reproductive Med. 43(1):3-10 (Exhibit 1).
European Search Report dated Mar. 20, 2003 (Exhibit 2).
European Search Report (supplemental) dated Apr. 10, 2003. Huang, S. et al. (1988) “A chromatofocusing study of human chorionic gonadotropin in biological fluids in normal pregnancy, pre-eclampsia and choriocarcinoma,” J. Formos Med. Assoc. 87:1036-44.
Kovalevskaya, G. et al. (2002) “Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope,” J. Endocrinology 172: 497-506.
Rau, B. et al. (1995) “Significance of beta-hCG in the serum as a tumor marker for gastric cancer,” Langenbecks Arch. Cher. 380:359-64; Only English Abstract considered.
European Search Report dated Nov. 20, 2002 (Exhibit 7).
Bogart et al., (1989) “Human Chorionic Gonadotropin Levels in Pregnancies with Aneuploid Fetuses”,Prenat. Diagn,9:379-384. (Exhibit 1).
Bogart et al., (1987) “Abnormal Maternal Serum Chorionic Gonadotropin Levels in Pregnancies with Fetal Chromosome Abnormalities”,Prenat. Diagn.7:623-630. (Exhibit 2).
Cole et al., (1997) “Oligosaccharide Variants of hCG-related Molecules: Potential Screening Markers for Down Syndrome”,Prenat. Diagn.17:1188-1190. (Exhibit 3).
Cole et al., (1998) “Hyperglycosylated hCG, A Potential Alternative To hCG in Down Syndrome Screening”,Pregnat. Diagn.18:926-933. (Exhibit 4).
Cole et al., (1997) “Urine β-Core Fragment, a Potential Screening Test for Ectopic Pregnancy And Sontaneous Abortion”,Fetal. Diagn. Ther.12:336-339. (Exhibit 5).
Forest et al., (1995) “Screening for Down Syndrome During the First and Second Trimesters: Impact of Risk Estimation Parameters”,Clin. Biochem.28:443-449. (Exhibit 6).
Kovalevskaya et al., (1999) “Early Pregnancy Human Chorionic Gonadotropin (hCG) Isoforms Measured By an Immunometric Assay for Choriocarcinoma-like hCG”,J. Endocrinol.161: 99-106. (Exhibit 7).
Spencer et al., (1996) “Urine Free beta-hCG and Beta Core in Pregnancies Affected by Down's Syndrome”,Prenat.Diagn.16: 605-613. (Exhibit 8).
Spencer et al., (1993) “Stability of Intact Chorionic Gonadotropin (hCG) in Serum, Liquid Whole Blood, and Dried Whole-Blood Filter-Paper Spots: Impact on Screening for Down Syndrome by Measurement of Free β-hCG Subunit”,Clin.Chem.39: 1064-1068. (Exhibit 9).
Spencer et al., (1997) “Biochemical Markers of Trisomy 21 in Amniotic Fluid”,Prenat.Diagn.17:31-37. (Exhibit 10).
Valerio et al., (1996) “Maternal Serum Screening of Fetal Chromosomal Abnormalities by AFP, UE3, hCG and free-βhCG”,Minerva. Ginecol.48: 169-173. (Exhibit 11).
Wald et al., (1994) “Four-Marker Serum Screening For Down's Syndrome”,Prenat.Diagn.14: 707-716. (Exhibit 12).
Wald et al., (1994) “First Trimester Biochemical Screening for Down's Syndrome”,Ann.Med.26: 23-29. (Exhibit 13).
Zimmermann et al., (1996) “Age-Independent Indices in Second-Trimester Serum Screening for Down's Syndrome Are Useless”,Prenat.Diagn.16: 79-82. (Exhibit 14).
Birken et al., (1993) “Separation of Nicked Human Chorionic Gonadotropin (hCG), Intact hCG, and hCG Beta Fragment From Standard Reference Preparations and Raw Urine Samples”,Endocrinology133: 1990-1397.
Birken et al., (1996) “Metabolism of hCG and hLH to Multiple Urinary Forms”,Mol. Cell Endocrinol.125: 121-131.
Birken et al., (1996) “Isolation and Characterization of Human Pituitary Chorionic Gonadotropin”,Endocrinology137: 1402-1411.
Cole et al., (1993) “The Deactivation of hCG by Nicking and Dissociation”,J. Clin. Endocrinol. Metab.76: 704-710.
Cole et al., (1985) “The Structures of the Serine-linked Sugar Chains on Human Chorionic Gonadotropin”,Biochem.Biophys.Res.Commun.126:333-339.
Ellish et al., (1996) “A Prospective Study of Early Pregnancy Loss”,Hum.Reprod.11: 406-412.
Hoermann et al., (1994) “Immunological Recognition and Clinical Significance of Nicked Human Chorionic Gonadotropin in Testicular Cancer”,Clin.Chem.40: 2306-2312.
Kovalevskaya et al., (1995) “HLH Beta Core Fragment Immunoreactivity in the Urine of Ovulating Women: A Sensitive and Specific Immunometric Assay for its Detection”,Endocrine3: 881-887.
O'Connor et al., (1984) “Recent Advances in the Chemistry and Immunochemistry of Human Chorionic Gonadotropin: Impact on Clinical Measurements”,Endocr.Rev.15: 650-683.
O'Connor et al., (1998) “Differential Urinary Gonadotropin Profiles in Early Pregnancy and Early Pregnancy Loss”,Prenat.Diagn.18: 1232-1240. (Pages 1-9 Exhibit 10).
O'Connor et al., (1998) “Development of Highly Sensitive Immunoassays to Measure Human Chorionic Gonadotropin, its Beta-subunit, and Beta Core Fragment in the Urine: Application to Malignancies”,Cancer Res.48: 1361-1366.
Wilcox et al., (1988) “Incidence of Early Loss of Pregnancy”,N.Engl.J.Med.319: 189-194.
Zinaman et al., (1996) “Estimates of Human Fertility and Pregnancy Loss”,Fertil.Steril.65: 503-509.
Acevedo et al., (1992) “Expression of Membrane-associated Human Chorionic Gonadotropin, Its Subunits, and Fragments by Cultured Human Cancer Cells”,Cancer69(7): 1829-1842.
Berger et al., (1993) “Variants of Human Chorionic Gonadotropin from Pregnant Women and Tumor Patients Recognized by Monoclonal Antibodies”,J. Clin. Endocrinol. and Metabolism77(2): 347-351.
Birken et al., (1999) “Development and Characterization of Chorionic Gonadotropin in Serum and Urine from Patients with Trophoblastic Tumors”,Clinical Investigation71: 953-960.
Cole et al., (1991) “The Heterogeneity of Human Chorionic Gonadotropin (hCG). III. The Occurrence and Biological and Immunological Activities of Nic
Birken Steven
Kovalevskaya Galina
O'Connor John
Cook Lisa V
Cooper & Dunham LLP
Le Long V.
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Methods for detecting trophoblast malignancy by HCG assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting trophoblast malignancy by HCG assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting trophoblast malignancy by HCG assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477948